...
首页> 外文期刊>Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA >Implantation of tissue-engineered cartilage-like tissue for the treatment for full-thickness cartilage defects of the knee
【24h】

Implantation of tissue-engineered cartilage-like tissue for the treatment for full-thickness cartilage defects of the knee

机译:植入组织工程软骨样组织以治疗膝盖全层软骨缺损

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The purposes of this study were to evaluate early- to midterm clinical results after implantation of tissue-engineered cartilage-like tissue for the treatment for full-thickness cartilage defects of the knee and to identify the factors affecting the final clinical results. Methods: Tissue-engineered cartilage-like tissue was prepared by culturing autologous chondrocytes in atelocollagen gel for 3-4 weeks. A total of 73 knees of 72 patients with full-thickness cartilage defects were implanted with this tissue-engineered cartilage-like tissue. The follow-up of these patients for >5 years (range 5-11 years, median 8.0 years) is reported. The patients were evaluated clinically using a rating scale, as well as arthroscopically, biomechanically, and histologically. A modified magnetic resonance observation of cartilage repair tissue (MOCART) system was used to quantify the magnetic resonance imaging (MRI) findings of the lesions. The patient or defect factors influencing the final clinical outcomes were also investigated. Results: Clinical rating improved significantly after implantation of tissue-engineered cartilage-like tissue. Arthroscopic findings at 2 years after implantation were graded as normal or nearly normal according to the International Cartilage Repair Society (ICRS) scale in 64 of 73 knees (87.7 %). Biomechanically, stiffness of the graft almost equalled the surrounding normal cartilage (87.9-102.5 %) at 2 years after implantation. Histologically, overall assessment of the repaired tissue by ICRS Visual Assessment Scale II was 70.4 ± 20.8. The average MOCART score was 13.5 ± 11.3 (0-45) preoperatively, 66.6 ± 16.8 (10-90) at 1 year after implantation, 70.4 ± 16.1 (15-90) at 2 years after implantation, and 72.5 ± 17.4 (15-95) at the final follow-up, indicating that MRI results were maintained. Among the factors investigated, only arthroscopic grade of the repaired lesion at 2 years after implantation was significantly correlated with the final clinical scores. Conclusions: Implantation of tissue-engineered cartilage-like tissue for the cartilage defects of the knee was effective in short- to midterm post-operatively. This procedure can be proposed as one option for repairing full-thickness cartilage defect of the knee. Level of evidence: IV.
机译:目的:本研究的目的是评估植入组织工程软骨样组织后治疗膝关节全层软骨缺损的早期至中期临床结果,并确定影响最终临床结果的因素。方法:通过在胶原蛋白凝胶中培养自体软骨细胞3-4周,制备组织工程化的软骨样组织。这种组织工程化的软骨样组织植入了72例全厚度软骨缺损患者中的总共73个膝盖。据报道,这些患者的随访时间超过5年(范围5-11年,中位8.0年)。使用评级量表以及关节镜,生物力学和组织学对患者进行临床评估。改进的软骨修复组织磁共振成像(MOCART)系统用于量化病变的磁共振成像(MRI)结果。还研究了影响最终临床结局的患者或缺陷因素。结果:植入组织工程软骨样组织后,临床评分显着提高。根据国际软骨修复学会(ICRS)评分,植入后2年的关节镜检查结果在73膝中的64膝中评分为正常或接近正常(87.7%)。从生物力学上讲,移植后2年,移植物的刚度几乎等于周围的正常软骨(87.9-102.5%)。组织学上,通过ICRS视觉评估量表II对修复的组织进行的总体评估为70.4±20.8。术前平均MOCART评分为13.5±11.3(0-45),植入后1年为66.6±16.8(10-90),植入后2年为70.4±16.1(15-90)和72.5±17.4(15-90) 95)在最后的随访中,表明MRI结果得以维持。在所调查的因素中,只有在植入后2年的关节镜下修复病变的等级才与最终临床评分显着相关。结论:在膝关节软骨缺损处植入组织工程软骨样组织在术后短期至中期均有效。可以将这一程序作为修复膝盖全层软骨缺损的一种选择。证据级别:IV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号